Jared Kelly
CIK: 0002103581
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCOLYTICS BIOTECH INC
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026ONCY
ONCOLYTICS BIOTECH INC
Award(A)DirectStock Option
755K shares- - Mar 12, 2026ONCY
ONCOLYTICS BIOTECH INC
Purchase(P)Direct5.1K shares at avg. $0.96$5K - Feb 12, 2026ONCY
ONCOLYTICS BIOTECH INC
Purchase(P)Direct29.5K shares at avg. $0.84$25K - Feb 11, 2026ONCY
ONCOLYTICS BIOTECH INC
Purchase(P)Direct5.6K shares at avg. $0.84$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 | ONCY ONCOLYTICS BIOTECH INC | Award(A) Stock Option | 755,000 | - | - | Direct |
| Mar 12, 2026 | ONCY ONCOLYTICS BIOTECH INC | Purchase(P) | 5,050 | $0.96 | $4,848 | Direct |
| Feb 12, 2026 | ONCY ONCOLYTICS BIOTECH INC | Purchase(P) | 29,500 | $0.84 | $24,839 | Direct |
| Feb 11, 2026 | ONCY ONCOLYTICS BIOTECH INC | Purchase(P) | 5,600 | $0.84 | $4,682 | Direct |
1-4 of 4 transactions
About Kelly Jared
Kelly Jared (SEC CIK 0002103581) files insider reports with the SEC as Chief Executive Officer of ONCOLYTICS BIOTECH INC (ONCY).
Signal8 holds 4 ownership filings by Kelly Jared (1 Form 3, 3 Form 4), filed between Jan 2, 2026 and Jun 3, 2026. Those filings report 4 transactions, from Feb 11, 2026 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kelly Jared's filings is in SAN DIEGO, CA.
Recent filings by Kelly Jared
Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)
- McAdory John Bearden, Chief Operating Officer
- Pisano Wayne, Director
- RIGBY JONATHAN, Director
- Holtham Angela, Director
- Parsons James T., Director
- Look Kirk, Chief Financial Officer